Cooley advised Vaxcyte, while Latham & Watkins represented the underwriters on the offering. Vaxcyte, a clinical-stage vaccine innovation company, announced its underwritten public offering of common stock and...
Vaxcyte’s $690 Million Public Offering
Jonah Energy’s $750 Million Notes Offering
Weil advised Guggenheim Securities on the deal while Vinson & Elkins advised Jonah Energy. Jonah Energy LLC announced a $750 million issuance of 144A/Reg S and privately...
Spring Valley Acquisition II’s $230 Million Initial Public Offering
Shearman & Sterling advised the underwriters on the transaction. Spring Valley Acquisition II, a special purpose acquisition company, executed the initial public offering of 23.0 million units...
Revance Therapeutics’ $200 Million Common Stock Offering
Cooley represented Revance, while Morgan Lewis represented Goldman Sachs & Co. LLC, Cowen and Company LLC, and Guggenheim Securities LLC, as joint book-running managers in the...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
First Watch Restaurant’s Secondary Public Offering
Latham & Watkins represented the underwriters in the offering. First Watch Restaurant Group, Inc. (NASDAQ: FWRG), the Daytime Dining concept serving breakfast, brunch and lunch, has...
POINT Biopharma’s $125 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. POINT Biopharma Global Inc. (NASDAQ: PNT), a company accelerating the discovery, development and global access to life-changing...
Portillo’s $218.5 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, closed on...
Sunnova Energy International’s $500 Million Notes Offering
Vinson & Elkins served as underwriters’ counsel on the deal. Sunnova Energy International Inc. announced its offering of $500 million aggregate principal amount of 2.625% convertible senior...
Revolution Medicines’ $230 Million Shares Offering
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
Cogent Biosciences’ $150 Million Upsized Shares Offering and Pre-funded Warrants
Latham & Watkins represented the underwriters in the offering. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases,...
European Wax Center’s $96,7 Common Stock Offering
Latham & Watkins represented the underwriters in the offering. European Wax Center, Inc. (NASDAQ: EWCZ), the largest and fastest-growing franchisor and operator of out-of-home waxing services...